TR200200111T2 - Neoplazmalar için terapötik ve profilaktik maddeler - Google Patents

Neoplazmalar için terapötik ve profilaktik maddeler

Info

Publication number
TR200200111T2
TR200200111T2 TR2002/00111T TR200200111T TR200200111T2 TR 200200111 T2 TR200200111 T2 TR 200200111T2 TR 2002/00111 T TR2002/00111 T TR 2002/00111T TR 200200111 T TR200200111 T TR 200200111T TR 200200111 T2 TR200200111 T2 TR 200200111T2
Authority
TR
Turkey
Prior art keywords
neoplasms
prophylactic agents
therapeutic
compound
neoplasm
Prior art date
Application number
TR2002/00111T
Other languages
English (en)
Inventor
Kurakata Shinichi
Fujiwara Kosaku
Fujita Takashi
Original Assignee
Sankyo Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Company Limited filed Critical Sankyo Company Limited
Publication of TR200200111T2 publication Critical patent/TR200200111T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34—Oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Bu bulus, neoplazmalar için aktif madde olarak füzyonlu bir heterosiklik bilesimi veya farmasötik olarak kabul edilebilir bir tuzunu içeren terapötik ve profilaktik maddelerle; böylece bir bilesimin neoplazma tedavisi veya önlenmesi için bir ilacin hazirlanmasinda kullanimiyla; ve sicak kanli bir hayvana (tercihe göre bir insana) böyle bir bilesimden farmasötik olarak etkili bir miktarda verilmesini içeren bir yöntemle ilgilidir.
TR2002/00111T 1999-07-19 2000-07-19 Neoplazmalar için terapötik ve profilaktik maddeler TR200200111T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20447699 1999-07-19

Publications (1)

Publication Number Publication Date
TR200200111T2 true TR200200111T2 (tr) 2002-08-21

Family

ID=16491170

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/00111T TR200200111T2 (tr) 1999-07-19 2000-07-19 Neoplazmalar için terapötik ve profilaktik maddeler

Country Status (18)

Country Link
US (1) US6569877B2 (tr)
EP (1) EP1197211A4 (tr)
KR (1) KR20020015383A (tr)
CN (1) CN1374864A (tr)
AU (1) AU760917B2 (tr)
BR (1) BR0012591A (tr)
CA (1) CA2379662A1 (tr)
CZ (1) CZ2002178A3 (tr)
HU (1) HUP0202340A3 (tr)
IL (1) IL147593A0 (tr)
MX (1) MXPA02000757A (tr)
NO (1) NO20020291L (tr)
NZ (1) NZ516636A (tr)
PL (1) PL352681A1 (tr)
RU (1) RU2219928C2 (tr)
TR (1) TR200200111T2 (tr)
WO (1) WO2001005402A1 (tr)
ZA (1) ZA200200316B (tr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI284533B (en) * 1999-05-24 2007-08-01 Sankyo Co Pharmaceutical composition for treating hyperglycemia, impaired glucose tolerance, diabetes complications and for improving insulin resistant
US9092523B2 (en) 2005-02-28 2015-07-28 Search Engine Technologies, Llc Methods of and systems for searching by incorporating user-entered information
EP1866738A4 (en) 2005-03-18 2010-09-15 Search Engine Technologies Llc USER FEEDBACK RESEARCH ENGINE FOR IMPROVING RESEARCH RESULTS
TW200745099A (en) * 2006-03-02 2007-12-16 Sankyo Co Optically active thiazolidinedione derivatives

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3152992B2 (ja) * 1992-04-03 2001-04-03 株式会社興人 過酸化脂質の生成抑制及び消去用組成物
DK0805155T3 (da) * 1994-09-28 2002-07-08 Nippon Suisan Kaisha Ltd Hidtil ukendt tricyklisk, kondenseret heterocyklisk antioxidantforbindelse
JP3820601B2 (ja) * 1995-03-27 2006-09-13 大塚製薬株式会社 活性酸素消去剤
IL118474A (en) * 1995-06-01 2001-08-08 Sankyo Co Benzimideol derivatives and pharmaceutical preparations containing them
US5814647A (en) * 1997-03-04 1998-09-29 Board Of Regents, The University Of Texas System Use of troglitazone and related compounds for the treatment of the climacteric symptoms
PL200859B1 (pl) * 1997-10-08 2009-02-27 Sankyo Co Podstawiony skondensowany związek heterocykliczny, kompozycja farmaceutyczna zawierająca podstawiony skondensowany związek heterocykliczny oraz zastosowanie podstawionego skondensowanego związku heterocyklicznego
AU1507799A (en) * 1997-12-16 1999-07-05 Sankyo Company Limited Leukemia remedy
US6878896B2 (en) * 2002-07-24 2005-04-12 United Parcel Service Of America, Inc. Synchronous semi-automatic parallel sorting

Also Published As

Publication number Publication date
HUP0202340A2 (hu) 2003-02-28
KR20020015383A (ko) 2002-02-27
US6569877B2 (en) 2003-05-27
IL147593A0 (en) 2002-08-14
EP1197211A1 (en) 2002-04-17
CZ2002178A3 (cs) 2002-05-15
CA2379662A1 (en) 2001-01-25
CN1374864A (zh) 2002-10-16
NO20020291D0 (no) 2002-01-18
NZ516636A (en) 2004-01-30
ZA200200316B (en) 2003-06-25
NO20020291L (no) 2002-03-18
MXPA02000757A (es) 2002-07-22
US20020137776A1 (en) 2002-09-26
AU760917B2 (en) 2003-05-22
EP1197211A4 (en) 2004-09-01
RU2219928C2 (ru) 2003-12-27
AU6021200A (en) 2001-02-05
BR0012591A (pt) 2002-04-09
PL352681A1 (en) 2003-09-08
HUP0202340A3 (en) 2006-03-28
WO2001005402A1 (fr) 2001-01-25

Similar Documents

Publication Publication Date Title
HK1057752A1 (en) N-phenyl-2-pyrimidine-amine derivatives
TR199903053T2 (tr) Benzimidazol türevleri.
TR199901417T2 (tr) Analjezik etkisi olan yeni bilesimler.
SE0002754D0 (sv) New pharmaceutical combination formulation and method of treatment with the combination
SE9900961D0 (sv) Novel compounds
CY1111698T1 (el) Συνδυασμος που περιλαμβανει εναν ανταγωνιστη υποδοχεα ατ1 και εναν ενισχυτη εκκρισης ινσουλινης ή εναν ευαισθητοποιητη ινσουλινης
TR200002969T2 (tr) Farmasötik bileşim.
SE9802208D0 (sv) Novel compounds
NO20000446L (no) Anvendelse av fysiologisk akseptable vanadiumforbindelser, - salter og -komplekser
MXPA02002452A (es) Agentes preventivos y terapeuticos para enfermedades de oftalmicas.
TR200102512T2 (tr) Tüm ruhsal bozukluklar, adaptasyon bozuklukları ve çeşitli kaygı-depresyon bozukluklarının tedavisinde ya da önlenmesinde yararlı tıbbi ürünlerin hazırlanması için saredutan ve onun farmasötik olarak kabul edilebilir tuzlarının kullanımı.
BR9913982A (pt) Derivado de piridil-4h-1,2,4-oxadiazina opticamente ativo e seu uso no tratamento de doenças vasculares
TR200200913T2 (tr) Bir NK1 reseptörü antagonistini ve bir gaba yapısal analoğunun sinerjik kombinasyonları.
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
SE9802209D0 (sv) Novel compounds
TR200200111T2 (tr) Neoplazmalar için terapötik ve profilaktik maddeler
BR0007686A (pt) Uso de antagonistas receptores da angiotensina ii para tratar enfartação miocárdia aguda
MXPA05012299A (es) Composicion farmaceutica que comprende valsartan.
SE9902387D0 (sv) New pharmaceutically active compounds
GEP20043231B (en) Resorcinol Composition
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
TR200201654T2 (tr) Benzamidin türevleri.
SE9802538D0 (sv) New pharmaceutically active compounds
DK0648117T3 (da) Lægemiddel til at forebygge udvikling af tolerance ved behandling med benzodiazepin-receptor-bindende aktive forbindelser
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань